Bright Minds Biosciences Inc.

DRUG· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$73.78+0.71%

2026-08-03

Valuation Metrics

Bright Minds Biosciences Inc.'s Market Cap is $722M. At end of 2025 it was $606M. Ranked #2645 of 3,111 in US market (top 85%), #1118 of 1,445 on NASDAQ (top 77%), #207 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 77%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$722M	US#2,645/3,111 Sec#207/269
Revenue	$0.00	US#2,980/3,111 Sec#205/269
Net Income	$-20M	US—/3,111 Sec—/269
Total Assets	$224M	US#2,970/3,111 Sec#244/269
Net Assets	$222M	US#2,705/3,111 Sec#190/269
Value
P/B	3.26x	US#1,790/3,111 Sec#97/269
FCF Yield	-1.99%	US—/3,111 Sec—/269
Profitability
ROE	-8.89%	US#2,392/3,111 Sec#88/269
ROA	-8.78%	US#2,635/3,111 Sec#102/269
Financial Health
Debt Ratio	1.24%	US#11/3,111 Sec#1/269
Total Debt	$58975.00	US#2,998/3,111 Sec#264/269
FCF	$-14M	US#2,361/3,111 Sec#91/269
Cash	$222M	US#1,653/3,111 Sec#108/269
Current Ratio	81.48x	US#38/3,111 Sec#1/269
Performance
1Y Return	119.39%	US#227/3,111 Sec#71/269
1M Return	9.14%	US#475/3,111 Sec#28/269
From 52W High	-40.38%	US#2,510/3,111 Sec#197/269
1Y MDD	-38.36%	US#1,875/3,111 Sec#138/269
Trading
Volume	275,786 shares	US#2,587/3,111 Sec#245/269
Trading Value	$20M	US#2,077/3,111 Sec#158/269
Per Share
EPS	$-2.56	US—/3,111 Sec—/269
BPS	$11.50	US#1,692/3,111 Sec#57/269